North America Stem Cell Therapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, and Other Stem Cell Therapy), Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Hospitals & Specialty Clinics and Academic & Research Institutes)
The North America stem cell therapy market was valued at US$ 1,299.39 million in 2022 and is projected to reach US$ 3,582.26 million by 2028; it is expected to grow at a CAGR of 18.4% from 2022 to 2028.
Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management is Driving the North America Stem Cell Therapy Market
Stem cell therapy has been widely investigated across the world. Stem cells are mainly used to replace dying cells and reconstruct damaged tissues. Based on the results of extensive stem cell research conducted so far, many scientists have claimed that these cells could probably be utilized to generate cures and treatments for diseases such as cancer and cardiovascular disease. Newly developed stem cell therapies involve replacing disease-causing cells with stem cells. Many potential treatments involving stem cells are in different phases of clinical trials. The FDA has also approved a few stem cell therapies involved in treating complications related to stem cell transplants. In September 2021, the US Food and Drug Administration (FDA) announced approval for 'Ruxolitinib' for treating 'graft-versus-host-disease' (GVHD) in patients aged 12 and above. Ruxolitinib provides a patient new hope that suffers from fatal complications associated with stem cell transplants.
Researchers are further investigating the use of stem cell therapy in treating autoimmune disorders. For example, stem cells can turn into the cells of damaged organs and are used in treating autoimmune diseases. Treatment is carried out using mesenchymal stem cells or fetal stem cells. Hematopoietic stem cells are currently used for treating more than 80 medicals conditions, including immune system diseases, blood disorders, neurological disorders, metabolic disorders, genetic disorders, and cancer types such as leukemia and lymphoma.
North America Stem Cell Therapy Market Overview
The North America stem cell therapy market has been segmented into the US, Canada, and Mexico. The US held the largest share of the North American stem cell therapy market in 2021. Growing awareness regarding the utilization of stem cells for disease treatment, favorable reimbursement policies for stem cell therapy research & development activities, increasing emphasis on stem cell banking, and the major presence of the key players in this market are among the factors are projected to accelerate the stem cell therapy market growth.
In Canada, the market is expected to grow owing to the development of the healthcare systems and rapidly increasing investments in stem cell therapy technology. On the other hand, in Mexico, it is expected that the stem cell therapy market in Mexico is likely to experience growth opportunities due increasing awareness of benefits offered by stem cell therapy.
Exhibit: North America Stem Cell Therapy Market Revenue and Forecast to 2028 (US$ Million)
North America Stem Cell Therapy Market Segmentation
The North America stem cell therapy market is segmented into type, treatment, application, end user, and country.
The North America stem cell therapy market, by type, is segmented into adult stem cell therapy, induced pluripotent stem cell therapy, embryonic stem cell therapy, and other stem cell therapy. The adult stem cell therapy segment held the largest market share in 2022.
Based on treatment, the North America stem cell therapy market is bifurcated into allogeneic and autologous. The allogenic segment held the largest share of the market in 2022.
Based on application, the North America stem cell therapy market is divided into musculoskeletal, dermatology, cardiology, drug discovery and development, other applications. The musculoskeletal segment held the largest share of the market in 2022.
The North America stem cell therapy market, by end user, is segmented into academic & research institutes and hospitals & clinics. The academic & research institutes segment held the largest share of the market in 2022.
Based on country, the North America stem cell therapy market is segmented into the US, Canada, and Mexico. The US dominated the market in 2022.
MEDIPOST; RichSource; BioTime, Inc.; Mesoblast Limited; U.S. Stem Cell, Inc.; TiGenix NV; AlloSource; and NuVasive Inc are the leading companies operating in the North America stem cell therapy market.
Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management is Driving the North America Stem Cell Therapy Market
Stem cell therapy has been widely investigated across the world. Stem cells are mainly used to replace dying cells and reconstruct damaged tissues. Based on the results of extensive stem cell research conducted so far, many scientists have claimed that these cells could probably be utilized to generate cures and treatments for diseases such as cancer and cardiovascular disease. Newly developed stem cell therapies involve replacing disease-causing cells with stem cells. Many potential treatments involving stem cells are in different phases of clinical trials. The FDA has also approved a few stem cell therapies involved in treating complications related to stem cell transplants. In September 2021, the US Food and Drug Administration (FDA) announced approval for 'Ruxolitinib' for treating 'graft-versus-host-disease' (GVHD) in patients aged 12 and above. Ruxolitinib provides a patient new hope that suffers from fatal complications associated with stem cell transplants.
Researchers are further investigating the use of stem cell therapy in treating autoimmune disorders. For example, stem cells can turn into the cells of damaged organs and are used in treating autoimmune diseases. Treatment is carried out using mesenchymal stem cells or fetal stem cells. Hematopoietic stem cells are currently used for treating more than 80 medicals conditions, including immune system diseases, blood disorders, neurological disorders, metabolic disorders, genetic disorders, and cancer types such as leukemia and lymphoma.
North America Stem Cell Therapy Market Overview
The North America stem cell therapy market has been segmented into the US, Canada, and Mexico. The US held the largest share of the North American stem cell therapy market in 2021. Growing awareness regarding the utilization of stem cells for disease treatment, favorable reimbursement policies for stem cell therapy research & development activities, increasing emphasis on stem cell banking, and the major presence of the key players in this market are among the factors are projected to accelerate the stem cell therapy market growth.
In Canada, the market is expected to grow owing to the development of the healthcare systems and rapidly increasing investments in stem cell therapy technology. On the other hand, in Mexico, it is expected that the stem cell therapy market in Mexico is likely to experience growth opportunities due increasing awareness of benefits offered by stem cell therapy.
Exhibit: North America Stem Cell Therapy Market Revenue and Forecast to 2028 (US$ Million)
North America Stem Cell Therapy Market Segmentation
The North America stem cell therapy market is segmented into type, treatment, application, end user, and country.
The North America stem cell therapy market, by type, is segmented into adult stem cell therapy, induced pluripotent stem cell therapy, embryonic stem cell therapy, and other stem cell therapy. The adult stem cell therapy segment held the largest market share in 2022.
Based on treatment, the North America stem cell therapy market is bifurcated into allogeneic and autologous. The allogenic segment held the largest share of the market in 2022.
Based on application, the North America stem cell therapy market is divided into musculoskeletal, dermatology, cardiology, drug discovery and development, other applications. The musculoskeletal segment held the largest share of the market in 2022.
The North America stem cell therapy market, by end user, is segmented into academic & research institutes and hospitals & clinics. The academic & research institutes segment held the largest share of the market in 2022.
Based on country, the North America stem cell therapy market is segmented into the US, Canada, and Mexico. The US dominated the market in 2022.
MEDIPOST; RichSource; BioTime, Inc.; Mesoblast Limited; U.S. Stem Cell, Inc.; TiGenix NV; AlloSource; and NuVasive Inc are the leading companies operating in the North America stem cell therapy market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Stem Cell Therapy Market – By Type
1.3.2 North America Stem Cell Therapy Market – By Treatment
1.3.3 North America Stem Cell Therapy Market – By Application
1.3.4 North America Stem Cell Therapy Market – By End User
1.3.5 North America Stem Cell Therapy Market – By Country
2. NORTH AMERICA STEM CELL THERAPY MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. NORTH AMERICA STEM CELL THERAPY MARKET– MARKET LANDSCAPE
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. NORTH AMERICA STEM CELL THERAPY MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management
5.1.2 Growing Prevalence of Cancer
5.2 Market Restraints
5.2.1 Availability of Illegal and Unapproved Products, and High Cost of Approved Treatments
5.3 Market Opportunities
5.3.1 Use of Induced Pluripotent Stem Cells in Regenerative Medicines
5.4 Future Trends
5.4.1 Research Activities and Product Innovations
5.5 Impact Analysis
6. STEM CELL THERAPY MARKET – NORTH AMERICA ANALYSIS
6.1 North America Stem Cell Therapy Market Revenue Forecast and Analysis
7. NORTH AMERICA STEM CELL THERAPY MARKET – REVENUE AND FORECAST TO 2028 – BY TYPE
7.1 Overview
7.2 North America Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Adult Stem Cell Therapy
7.3.1 Overview
7.3.2 Adult Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Hematopoietic Stem Cell Therapy
7.3.3.1 Overview
7.3.3.2 Hematopoietic Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Umbilical Cord Stem Cell Therapy
7.3.4.1 Overview
7.3.4.2 Umbilical Cord Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Neuronal Stem Cell Therapy
7.3.5.1 Overview
7.3.5.2 Neuronal Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Mesenchymal Stem Cell
7.3.6.1 Overview
7.3.6.2 Mesenchymal Stem Cell: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Embryonic Stem Cell Therapy
7.4.1 Overview
7.4.2 Embryonic Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Induced Pluripotent Stem Cell Therapy
7.5.1 Overview
7.5.2 Induced Pluripotent Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Other Stem Cell Therapy
7.6.1 Overview
7.6.2 Other Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8. NORTH AMERICA STEM CELL THERAPY MARKET ANALYSIS AND FORECASTS TO 2028 – BY TREATMENT
8.1 Overview
8.2 North America Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
8.3 Allogeneic
8.3.1 Overview
8.3.2 Allogeneic: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Autologous
8.4.1 Overview
8.4.2 Autologous: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9. NORTH AMERICA STEM CELL THERAPY MARKET ANALYSIS AND FORECASTS TO 2028 – BY APPLICATION
9.1 Overview
9.2 North America Stem Cell Therapy Market, by Application 2021 & 2028 (%)
9.3 Musculoskeletal
9.3.1 Overview
9.3.2 Musculoskeletal: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Dermatology
9.4.1 Overview
9.4.2 Dermatology: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Cardiology
9.5.1 Overview
9.5.2 Cardiology: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Drug Discovery and Development
9.6.1 Overview
9.6.2 Drug Discovery and Development: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Other Applications
9.7.1 Overview
9.7.2 Other Applications: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10. NORTH AMERICA STEM CELL THERAPY MARKET – REVENUE AND FORECAST TO 2028 – BY END USER
10.1 Overview
10.2 North America Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
10.3 Academic & Research Institutes
10.3.1 Overview
10.3.2 Academic & Research Institutes: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Hospitals & Specialty Clinics
10.4.1 Overview
10.4.2 Hospitals & Specialty Clinics: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11. NORTH AMERICA STEM CELL THERAPY MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
11.1 North America: Stem Cell Therapy Market
11.1.1 Overview
11.1.1.1 US: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 US: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 US: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.1.1.3.1 US: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.1.1.4 US: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.1.1.5 US: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.1.1.6 US: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.1.2 Canada: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 Canada: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 Canada: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.1.2.3.1 Canada: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.1.2.4 Canada: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.1.2.5 Canada: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.1.2.6 Canada: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.1.3 Mexico: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 Mexico: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 Mexico: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.1.3.3.1 Mexico: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.1.3.4 Mexico: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.1.3.5 Mexico: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.1.3.6 Mexico: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
12. STEM CELL THERAPY MARKET–INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies in the Stem Cell Therapy Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. COMPANY PROFILES
13.1 MEDIPOST
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 RichSource
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 BioTime, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Mesoblast Limited
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 U.S. Stem Cell, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 TiGenix NV
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 AlloSource
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 NuVasive Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
14.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Stem Cell Therapy Market – By Type
1.3.2 North America Stem Cell Therapy Market – By Treatment
1.3.3 North America Stem Cell Therapy Market – By Application
1.3.4 North America Stem Cell Therapy Market – By End User
1.3.5 North America Stem Cell Therapy Market – By Country
2. NORTH AMERICA STEM CELL THERAPY MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. NORTH AMERICA STEM CELL THERAPY MARKET– MARKET LANDSCAPE
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. NORTH AMERICA STEM CELL THERAPY MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management
5.1.2 Growing Prevalence of Cancer
5.2 Market Restraints
5.2.1 Availability of Illegal and Unapproved Products, and High Cost of Approved Treatments
5.3 Market Opportunities
5.3.1 Use of Induced Pluripotent Stem Cells in Regenerative Medicines
5.4 Future Trends
5.4.1 Research Activities and Product Innovations
5.5 Impact Analysis
6. STEM CELL THERAPY MARKET – NORTH AMERICA ANALYSIS
6.1 North America Stem Cell Therapy Market Revenue Forecast and Analysis
7. NORTH AMERICA STEM CELL THERAPY MARKET – REVENUE AND FORECAST TO 2028 – BY TYPE
7.1 Overview
7.2 North America Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Adult Stem Cell Therapy
7.3.1 Overview
7.3.2 Adult Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Hematopoietic Stem Cell Therapy
7.3.3.1 Overview
7.3.3.2 Hematopoietic Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Umbilical Cord Stem Cell Therapy
7.3.4.1 Overview
7.3.4.2 Umbilical Cord Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Neuronal Stem Cell Therapy
7.3.5.1 Overview
7.3.5.2 Neuronal Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Mesenchymal Stem Cell
7.3.6.1 Overview
7.3.6.2 Mesenchymal Stem Cell: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Embryonic Stem Cell Therapy
7.4.1 Overview
7.4.2 Embryonic Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Induced Pluripotent Stem Cell Therapy
7.5.1 Overview
7.5.2 Induced Pluripotent Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Other Stem Cell Therapy
7.6.1 Overview
7.6.2 Other Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8. NORTH AMERICA STEM CELL THERAPY MARKET ANALYSIS AND FORECASTS TO 2028 – BY TREATMENT
8.1 Overview
8.2 North America Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
8.3 Allogeneic
8.3.1 Overview
8.3.2 Allogeneic: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Autologous
8.4.1 Overview
8.4.2 Autologous: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9. NORTH AMERICA STEM CELL THERAPY MARKET ANALYSIS AND FORECASTS TO 2028 – BY APPLICATION
9.1 Overview
9.2 North America Stem Cell Therapy Market, by Application 2021 & 2028 (%)
9.3 Musculoskeletal
9.3.1 Overview
9.3.2 Musculoskeletal: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Dermatology
9.4.1 Overview
9.4.2 Dermatology: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Cardiology
9.5.1 Overview
9.5.2 Cardiology: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Drug Discovery and Development
9.6.1 Overview
9.6.2 Drug Discovery and Development: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Other Applications
9.7.1 Overview
9.7.2 Other Applications: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10. NORTH AMERICA STEM CELL THERAPY MARKET – REVENUE AND FORECAST TO 2028 – BY END USER
10.1 Overview
10.2 North America Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
10.3 Academic & Research Institutes
10.3.1 Overview
10.3.2 Academic & Research Institutes: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Hospitals & Specialty Clinics
10.4.1 Overview
10.4.2 Hospitals & Specialty Clinics: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11. NORTH AMERICA STEM CELL THERAPY MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
11.1 North America: Stem Cell Therapy Market
11.1.1 Overview
11.1.1.1 US: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 US: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 US: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.1.1.3.1 US: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.1.1.4 US: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.1.1.5 US: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.1.1.6 US: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.1.2 Canada: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 Canada: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 Canada: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.1.2.3.1 Canada: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.1.2.4 Canada: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.1.2.5 Canada: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.1.2.6 Canada: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.1.3 Mexico: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 Mexico: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 Mexico: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.1.3.3.1 Mexico: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.1.3.4 Mexico: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.1.3.5 Mexico: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.1.3.6 Mexico: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
12. STEM CELL THERAPY MARKET–INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies in the Stem Cell Therapy Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. COMPANY PROFILES
13.1 MEDIPOST
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 RichSource
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 BioTime, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Mesoblast Limited
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 U.S. Stem Cell, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 TiGenix NV
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 AlloSource
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 NuVasive Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Cost Expenditure of Stem Cell Injection
Table 2. US Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. US Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 4. US Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Organic Developments in the Stem Cell Therapy Market
Table 18. Inorganic Developments in the Stem Cell Therapy Market
Table 19. Glossary of Terms
Table 1. Cost Expenditure of Stem Cell Injection
Table 2. US Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. US Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 4. US Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Organic Developments in the Stem Cell Therapy Market
Table 18. Inorganic Developments in the Stem Cell Therapy Market
Table 19. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Stem Cell Therapy Market Segmentation
Figure 2. North America Stem Cell Therapy Segmentation, By Country
Figure 3. North America Stem Cell Therapy Market Overview
Figure 4. Adult Stem Cell Therapy Segment Held Largest Share of Type Segment in North America Stem Cell Therapy Market
Figure 5. US Is Expected to Show Remarkable Growth During the Forecast Period
Figure 7. North America: PEST Analysis
Figure 8. Experts Opinion
Figure 9. North America Stem Cell Therapy Market Impact Analysis of Drivers and Restraints
Figure 10. North America Stem Cell Therapy Market – Revenue Forecast and Analysis – 2020- 2028
Figure 11. North America Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
Figure 12. Adult Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Hematopoietic Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Umbilical Cord Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Neuronal Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Mesenchymal Stem Cell: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Embryonic Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Induced Pluripotent Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Other Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. North America Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
Figure 21. Allogeneic: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Autologous: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America Stem Cell Therapy Market, by Application 2021 & 2028 (%)
Figure 24. Musculoskeletal: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Dermatology: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cardiology: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Drug Discovery and Development: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Other Applications: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
Figure 30. Academic & Research Institutes: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Hospitals & Specialty Clinics: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. North America: Stem Cell Therapy Market, by Key Country – Revenue (2021) (US$ Million)
Figure 33. North America: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)
Figure 34. US: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Canada: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Mexico: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Growth Strategies in the Stem Cell Therapy Market (%)
Figure 1. North America Stem Cell Therapy Market Segmentation
Figure 2. North America Stem Cell Therapy Segmentation, By Country
Figure 3. North America Stem Cell Therapy Market Overview
Figure 4. Adult Stem Cell Therapy Segment Held Largest Share of Type Segment in North America Stem Cell Therapy Market
Figure 5. US Is Expected to Show Remarkable Growth During the Forecast Period
Figure 7. North America: PEST Analysis
Figure 8. Experts Opinion
Figure 9. North America Stem Cell Therapy Market Impact Analysis of Drivers and Restraints
Figure 10. North America Stem Cell Therapy Market – Revenue Forecast and Analysis – 2020- 2028
Figure 11. North America Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
Figure 12. Adult Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Hematopoietic Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Umbilical Cord Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Neuronal Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Mesenchymal Stem Cell: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Embryonic Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Induced Pluripotent Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Other Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. North America Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
Figure 21. Allogeneic: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Autologous: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America Stem Cell Therapy Market, by Application 2021 & 2028 (%)
Figure 24. Musculoskeletal: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Dermatology: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cardiology: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Drug Discovery and Development: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Other Applications: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
Figure 30. Academic & Research Institutes: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Hospitals & Specialty Clinics: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. North America: Stem Cell Therapy Market, by Key Country – Revenue (2021) (US$ Million)
Figure 33. North America: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)
Figure 34. US: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Canada: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Mexico: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Growth Strategies in the Stem Cell Therapy Market (%)
